{"id":109907,"date":"2020-07-13T22:42:54","date_gmt":"2020-07-14T05:42:54","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/07\/regeneron-stock-hits-another-record-high-on-coronavirus-treatment-potential"},"modified":"2020-07-13T22:42:54","modified_gmt":"2020-07-14T05:42:54","slug":"regeneron-stock-hits-another-record-high-on-coronavirus-treatment-potential","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/07\/regeneron-stock-hits-another-record-high-on-coronavirus-treatment-potential","title":{"rendered":"Regeneron Stock Hits Another Record High On Coronavirus Treatment Potential"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/regeneron-stock-hits-another-record-high-on-coronavirus-treatment-potential.jpg\"><\/a><\/p>\n<p>Regeneron rose as much as 2.4% in the stock market today, touching a record high of 655.93. Shares seesawed in a small range Thursday before ending the day up a small fraction, at 640.63. The peak price topped Regeneron stock\u2019s previous high of 653.53, touched on Tuesday. Regeneron is part of the IBD Biomed\/Biotech group, which ranks No. 14 out of 197 industry groups tracked. The group is just off its all-time high, which it hit on June 23.<\/p>\n<hr>\n<p>\n<strong>Regeneron Pharmaceuticals<\/strong> (<a class=\"\" href=\"https:\/\/research.investors.com\/quote.aspx?symbol=REGN\" target=\"_blank\">REGN<\/a>) jumped to an all-time high Thursday, its second of the week, as analysts remain bullish on Regeneron stock due to its coronavirus treatment and other businesses.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regeneron rose as much as 2.4% in the stock market today, touching a record high of 655.93. Shares seesawed in a small range Thursday before ending the day up a small fraction, at 640.63. The peak price topped Regeneron stock\u2019s previous high of 653.53, touched on Tuesday. Regeneron is part of the IBD Biomed\/Biotech group, [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,45],"tags":[],"class_list":["post-109907","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-finance"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/109907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=109907"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/109907\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=109907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=109907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=109907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}